Does Vyvanse (lisdexamfetamine) interfere with the menstrual cycle or cause missed periods in women of reproductive age?

Vyvanse Does Not Directly Cause Missed Periods or Menstrual Cycle Disruption

Based on current FDA labeling and clinical guidelines, Vyvanse (lisdexamfetamine) is not documented to interfere with menstrual cycles or cause missed periods. However, the medication's effects on appetite, weight, and stress hormones may indirectly influence menstrual regularity in some women.

What the Evidence Shows

Direct Effects on Menstruation

The FDA drug label for Vyvanse does not list menstrual irregularities or amenorrhea as adverse effects 1. The most comprehensive 2024 ADHD guidelines focusing on women of reproductive age similarly make no mention of menstrual cycle disruption as a concern with lisdexamfetamine 2.

Indirect Mechanisms That May Affect Cycles

Weight and Appetite Suppression:

• Vyvanse commonly causes decreased appetite and weight loss 1
• Significant weight loss from any cause can disrupt menstrual cycles through hypothalamic-pituitary-ovarian axis suppression
• This is a secondary effect of weight change, not a direct drug effect on reproductive hormones

HPA Axis Activation:

• Lisdexamfetamine stimulates the hypothalamic-pituitary-adrenal (HPA) axis, increasing cortisol, ACTH, and other stress hormones 3
• However, these effects are comparable to other amphetamines and have not been linked to menstrual disruption in clinical practice
• The HPA activation is weaker than with serotonergic drugs like MDMA 3

Menstrual Cycle Effects on Vyvanse Response (Not Vice Versa)

The relationship actually works in the opposite direction—menstrual hormones affect how women respond to amphetamines, not the other way around:

• Amphetamine effects are greater during the follicular phase (low progesterone) compared to the luteal phase (high progesterone) 4, 5
• Women report increased ADHD symptom worsening premenstrually, sometimes requiring dose adjustments 6, 7
• Estrogen appears to enhance stimulant effects, while progesterone may dampen them 8, 5

Clinical Approach to Missed Periods on Vyvanse

If a patient on Vyvanse reports missed periods, evaluate:

1. Pregnancy status (first priority—rule out pregnancy immediately)

2. Weight changes:

   • Quantify weight loss since starting medication
   • BMI calculation
   • Assess for eating disorder symptoms or excessive appetite suppression

3. Other causes of amenorrhea:

   • Polycystic ovary syndrome (PCOS)
   • Thyroid dysfunction
   • Hyperprolactinemia
   • Primary ovarian insufficiency
   • Stress and excessive exercise

4. Medication review:

   • Other medications that can affect cycles (antipsychotics, hormonal contraceptives)
   • Duration of Vyvanse use relative to menstrual changes

Management Recommendations

If significant weight loss is present:

• Consider dose reduction or medication holiday
• Nutritional counseling
• Monitor for return of menses with weight stabilization

If weight is stable:

• The missed periods are unlikely related to Vyvanse
• Pursue standard amenorrhea workup (FSH, LH, prolactin, TSH, pregnancy test)

Do not discontinue Vyvanse solely for menstrual irregularity unless significant weight loss or other concerning factors are present, as the medication is not a documented cause of cycle disruption.

Important Caveats

• Large doses of dextroamphetamine (the active metabolite of Vyvanse) "might interfere with milk production" in lactating women 1, but this does not extend to menstrual cycle effects
• The evidence base specifically for lisdexamfetamine and menstruation is limited 2, but decades of amphetamine use have not established menstrual disruption as a recognized adverse effect
• Individual variation exists—if temporal relationship is clear and other causes excluded, consider trial off medication